1 – 22 of 22
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
CYP3A7*1C allele : linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
(
- Contribution to journal › Article
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(
- Contribution to journal › Article
- 2020
-
Mark
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
(
- Contribution to journal › Letter
- 2018
-
Mark
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
MiR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome
(
- Contribution to journal › Article
- 2016
-
Mark
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
(
- Contribution to journal › Article
-
Mark
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
2016) In Nature Genetics(
- Contribution to journal › Article
-
Mark
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
(
- Contribution to journal › Article
-
Mark
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
(
- Contribution to journal › Article
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
(
- Contribution to journal › Article
-
Mark
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
(
- Contribution to journal › Article
- 2015
-
Mark
Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts
(
- Contribution to journal › Article
-
Mark
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
(
- Contribution to journal › Article
-
Mark
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
(
- Contribution to journal › Article
- 2014
-
Mark
Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3
(
- Contribution to journal › Article
-
Mark
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
(
- Contribution to journal › Article
-
Mark
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
(
- Contribution to journal › Article
- 2013
-
Mark
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
(
- Contribution to journal › Article
-
Mark
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
(
- Contribution to journal › Article
- 2010
-
Mark
Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients
(
- Contribution to journal › Article
-
Mark
Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility
(
- Contribution to journal › Article